Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term, Double Blind, Randomized, Placebo Controlled Multi-center Study of FRE.M.S.- Frequency Modulated Neural Stimulation Lorenz Therapy™ in Symptomatic Diabetic Neuropathy

NCT01628627 is registered in ClinicalTrials.gov with Lorenz Biotech S.p.A. as lead sponsor.

NCT NCT01628627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01628627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term, Double Blind, Randomized, Placebo Controlled Multi-center Study of FRE.M.S.- Frequency Modulated Neural Stimulation Lorenz Therapy™ in Symptomatic Diabetic Neuropathy
Lead sponsor
Lorenz Biotech S.p.A.
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
April 30, 2010
Enrollment
164 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful